| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |